NATIXIS - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 221 filers reported holding TRANSMEDICS GROUP INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.

Quarter-by-quarter ownership
NATIXIS ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$1,629,196
-43.7%
29,757
-13.7%
0.01%
-50.0%
Q2 2023$2,895,798
+10.3%
34,482
-0.6%
0.02%0.0%
Q1 2023$2,626,165
-40.4%
34,678
-51.4%
0.02%
-4.0%
Q4 2022$4,406,067
+171.5%
71,388
+93.0%
0.02%
+212.5%
Q3 2022$1,623,000
+88.7%
36,996
+30.6%
0.01%
+166.7%
Q2 2022$860,00028,3200.00%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sandhill Capital Partners LLC 1,805,518$34,594,0002.69%
Millrace Asset Group, Inc. 83,723$1,604,0000.94%
Bullseye Asset Management LLC 117,031$2,218,0000.88%
Taylor Wealth Management Partners 72,782$1,395,0000.49%
MOODY ALDRICH PARTNERS LLC 166,078$3,182,0000.44%
HARBOURVEST PARTNERS LLC 116,123$2,225,0000.28%
NEXT CENTURY GROWTH INVESTORS LLC 161,819$3,100,0000.28%
EMERALD MUTUAL FUND ADVISERS TRUST 300,492$5,757,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 82,255$1,576,0000.18%
EMERALD ADVISERS, LLC 244,816$4,691,0000.17%
View complete list of TRANSMEDICS GROUP INC shareholders